RUNX3 and gastric cancer: RUNX3 acts as a tumor suppressor in gastric cancer, colon cancer, and some other solid tumors, but it is usually inactivated during tumor progression due to loss of heterozygosity, promoter hypermethylation, histone modification, and protein mislocalization [7].